LRMR Larimar Therapeutics, Inc. - Common Stock
$4,27
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 4, 2026
Zakres 52 tyg.
$3–$6
42% of range
Ocena Analityków
STRONG BUY
17 analysts
Cena Docelowa
$14
+235% upside
P/E (TTM)
-2.5
ROE
-167.4%
Marża Zysku Netto
—
O Larimar Therapeutics, Inc. - Common Stock Przegląd firmy z Wikipedii
LRMR Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$4.26
Kapitalizacja Rynkowa
$354M
P/E (TTM)
-2.5
EPS (TTM)
$-1.32
Przychody (TTM)
—
Stopa dywidendy
—
ROE
-167.4%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$3 – $6
LRMR Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
2016-12-31
→
2019-12-31
EPS
$-1.32
2020-12-31
→
2024-12-31
Wolny przepływ pieniężny
$-113M
2016-12-31
→
2025-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
LRMR
Mediana porównawcza
P/E (TTM)
-2.5
15.7
P/B
4.5
4.8
Price / FCF (Cena / FCF)
-3.1
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
LRMR
Mediana porównawcza
ROA
-95.8%
-37.6%
ROE
-167.4%
-52.6%
ROIC
-220.9%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
LRMR
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
2.2
10.2
Quick Ratio (Wskaźnik Szybkości)
1.3
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
LRMR
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
LRMR
Mediana porównawcza
LRMR Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
17 analityków
- Mocne kupno 8 47,1%
- Kup 8 47,1%
- Trzymaj 1 5,9%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
10 analityków · 2026-08-18
Mediana
$12.50
Średnia
$14.30
← Poniżej wszystkich celów
$4.26
Niski
$5.00
Wysoki
$26.00
Średni cel
$12.50
+193,1%
Średnia cel
$14.30
+235,3%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.02%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.30 | $-0.39 | 0.09% |
| 31 marca 2026 | $-0.31 | $-0.55 | 0.24% |
| 31 grudnia 2025 | $-0.73 | $-0.52 | -0.21% |
| 30 września 2025 | $-0.61 | $-0.41 | -0.20% |
| 30 czerwca 2025 | $-0.41 | $-0.49 | 0.08% |
| 31 marca 2025 | $-0.46 | $-0.43 | -0.03% |
| 31 grudnia 2024 | $-0.45 | $-0.32 | -0.13% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| LRMR | $317M | -2.2 | — | — | -167.4% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| CMPX | $958M | — | — | — | -45.9% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
| LXEO | $725M | -5.3 | — | — | -51.9% | — |
| CAPR | $1.66B | -12.8 | -11.6% | — | -51.1% | — |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | — |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | — |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $154M | $73M | $28M | $24M | $38M | $31M | $21M | $48M | $41M | $40M | $55M | $27M | |
| SG&A Expense | $18M | $18M | $14M | $12M | $12M | $11M | $2M | $13M | $12M | $18M | $19M | $8M | |
| Operating Expenses | $172M | $91M | $42M | $37M | $50M | $43M | $23M | $61M | $53M | $58M | $74M | $36M | |
| Operating Income | $-172M | $-91M | $-42M | $-37M | $-50M | $-43M | $-23M | $-61M | $-53M | $-58M | $-74M | $-36M | |
| Interest Expense | · | · | · | · | · | · | $2M | $2M | $165.0K | $529.0K | $806.0K | $870.0K | |
| Interest Income | · | · | · | · | · | · | $2M | $2M | $996.0K | · | · | · | |
| Other Non-op | $7M | $10M | $5M | $1M | $-171.0K | $322.0K | $82.0K | $-246.0K | $971.0K | $347.0K | $-473.0K | $-946.0K | |
| Pretax Income | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| EPS (Basic) | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · | |
| EPS (Diluted) | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · | |
| Shares (Basic) | · | 61,256,084 | 43,901,241 | 25,761,394 | 17,164,284 | 11,883,155 | · | · | · | · | · | · | |
| Shares (Diluted) | · | 61,256,084 | 43,901,241 | 25,761,394 | 17,164,284 | 11,883,155 | · | · | · | · | · | · | |
| EBITDA | $-172M | $-91M | $-42M | $-37M | $-50M | $-43M | $-46M | $-61M | $-53M | $-58M | · | $-36M |
Bilans 23
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $33M | $27M | $27M | $70M | $68M | $1M | $49M | $41M | $32M | $36M | $58M | |
| Prepaid Expense | $5M | $12M | $3M | $2M | $2M | $5M | $4M | $2M | $2M | $1M | $2M | $1M | |
| Current Assets | $142M | $195M | $90M | $121M | $72M | $98M | $5M | $121M | $105M | $131M | $188M | $117M | |
| PP&E (Net) | $622.0K | $881.0K | $684.0K | $831.0K | $1M | $1M | $274.0K | $375.0K | $528.0K | $661.0K | $902.0K | $79.0K | |
| PP&E (Gross) | $3M | $2M | $2M | $2M | $2M | $1M | $453.0K | $925.0K | $1M | $981.0K | $1M | $129.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $914.0K | $596.0K | $335.0K | $179.0K | $550.0K | $508.0K | $320.0K | $120.0K | $50.0K | |
| Other Non-current Assets | $523.0K | $596.0K | $659.0K | $638.0K | $669.0K | $419.0K | $90.0K | $57.0K | $57.0K | $61.0K | $94.0K | $242.0K | |
| Total Assets | $146M | $200M | $96M | $126M | $79M | $105M | $5M | $122M | $106M | $132M | $189M | $118M | |
| Accounts Payable | $5M | $2M | $1M | $2M | $2M | $3M | $4M | $4M | $3M | $3M | $7M | $2M | |
| Accrued Liabilities | $58M | $21M | $7M | $8M | $7M | $6M | $2M | $4M | $4M | $4M | $6M | $3M | |
| Short-term Debt | · | · | · | · | · | · | $7M | $5M | · | $4M | $3M | $1M | |
| Current Liabilities | $65M | $24M | $10M | $11M | $9M | $9M | $6M | $13M | $7M | $10M | $17M | $7M | |
| Capital Leases | $3M | $4M | $5M | $5M | $5M | $6M | $6M | · | · | · | · | · | |
| Total Liabilities | $68M | $28M | $14M | $16M | $14M | $15M | $6M | $28M | $27M | $10M | $20M | $13M | |
| Long-term Debt | · | · | · | · | · | · | $15M | $20M | $20M | $3M | · | · | |
| Total Debt | · | · | · | · | · | · | $7M | $5M | · | $4M | · | $1M | |
| Common Stock | $83.0K | $64.0K | $43.0K | $43.0K | $18.0K | $15.0K | $6.0K | $37.0K | $27.0K | $27.0K | $27.0K | $23.0K | |
| Paid-in Capital | $513M | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-435M | $-269M | $-189M | $-152M | $-116M | $-66M | $-23M | $-351M | $-290M | $-238M | $-180M | $-105M | |
| AOCI | $54.0K | $148.0K | $81.0K | $-31.0K | · | $1.0K | $35.0K | $-33.0K | $-58.0K | $-80.0K | $-207.0K | $-35.0K | |
| Stockholders' Equity | $78M | $172M | $82M | $111M | $64M | $90M | $-694.0K | $3M | $78M | $122M | $169M | $104M | |
| Liabilities + Equity | $146M | $200M | $96M | $126M | $79M | $105M | $5M | $122M | $106M | $132M | $189M | $118M | |
| Shares Outstanding | 83,090,392 | 63,815,065 | 43,909,069 | 43,269,200 | 17,710,450 | 15,367,730 | 6,091,250 | 37,287,221 | 27,489,457 | 27,332,551 | 27,242,503 | 22,879,160 |
Przepływy pieniężne 11
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $9M | $8M | $7M | $5M | $2M | $129.0K | $10M | $8M | $10M | $9M | $2M | |
| Restructuring | · | · | · | · | · | · | $6M | · | · | $1M | · | · | |
| Operating Cash Flow | $-113M | $-71M | $-33M | $-28M | $-42M | $-42M | $-23M | $-51M | $-44M | $-52M | $-60M | $-28M | |
| CapEx | $91.0K | $515.0K | $164.0K | $100.0K | $333.0K | $62.0K | $83.0K | $108.0K | $55.0K | $660.0K | $595.0K | $58.0K | |
| Investing Cash Flow | $100M | $-85M | $33M | $-91M | $24M | $17M | $-83.0K | $-7M | $36M | $51M | · | · | |
| Stock Issued | $65M | $162M | · | $75M | $20M | $76M | · | $65M | · | · | $130M | $103M | |
| Net Stock Activity | $65M | $162M | · | $75M | $20M | $76M | · | $65M | · | · | · | · | |
| Financing Cash Flow | $65M | $162M | $30.0K | $75M | $20M | $94M | $19M | $67M | $17M | $-3M | · | · | |
| Net Change in Cash | $52M | $6M | $-76.0K | $-43M | $2M | $68M | $-3M | $9M | $8M | $-3M | $-23M | $23M | |
| Free Cash Flow | $-113M | $-71M | $-34M | $-28M | $-42M | $-42M | $-42M | $-52M | $-44M | $-53M | · | $-28M | |
| Levered FCF | · | · | · | · | · | · | $-43M | $-53M | $-44M | $-53M | · | $-29M |
Rentowność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -95.8% | -54.4% | -33.2% | -34.5% | -55.2% | -77.3% | -44.9% | -54.0% | -43.9% | -36.1% | · | -46.9% | |
| ROE | -167.4% | -43.5% | -42.4% | -30.8% | -74.2% | -44.2% | -163.6% | -62.2% | -52.0% | -39.8% | · | -203.4% | |
| ROIC | -220.9% | -52.9% | -51.1% | -32.9% | -78.3% | -47.7% | -75.0% | -61.9% | -67.8% | -46.5% | · | -33.6% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 8.0 | 9.5 | 11.3 | 8.2 | 10.9 | 5.9 | 9.1 | 14.4 | 13.2 | · | 17.0 | |
| Quick Ratio | 1.3 | 1.4 | 2.8 | 2.5 | 7.9 | 7.6 | 2.2 | 3.7 | 5.6 | 3.3 | · | 8.4 | |
| Debt / Equity | · | · | · | · | · | · | 0.1 | 0.1 | · | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | -25.9 | -32.2 | -321.2 | -110.1 | · | -40.8 |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 |
Wycena (TTM) 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| Market Cap | $317M | $247M | $200M | $179M | $191M | $329M | $499M | $2.21B | $1.52B | $1.04B | · | $8.47B | |
| Enterprise Value | · | · | · | · | · | · | $479M | $2.17B | · | $1.01B | · | $8.41B | |
| P/E | -2.2 | -2.9 | -5.4 | -3.0 | -3.7 | -6.0 | · | · | · | · | · | · | |
| P/B | 4.1 | 1.4 | 2.4 | 1.6 | 3.0 | 3.7 | 9.3 | 23.7 | 19.5 | 8.6 | · | 81.1 | |
| P / Tangible Book | 4.1 | 1.4 | 2.4 | 1.6 | 3.0 | 3.7 | · | · | · | · | · | · | |
| P / Cash Flow | -2.8 | -3.5 | -6.0 | -6.5 | -4.5 | -7.8 | -12.2 | -43.0 | -34.8 | -20.1 | · | -299.8 | |
| P / FCF | -2.8 | -3.5 | -5.9 | -6.5 | -4.5 | -7.8 | -12.0 | -42.9 | -34.8 | -19.8 | · | -299.2 | |
| EV / EBITDA | · | · | · | · | · | · | -10.5 | -35.5 | · | -17.4 | · | -236.7 | |
| EV / FCF | · | · | · | · | · | · | -11.5 | -42.1 | · | -19.3 | · | -297.2 | |
| Earnings Yield | -45.1% | -34.1% | -18.5% | -33.2% | -27.3% | -16.7% | · | · | · | · | · | · |
Rachunek zysków i strat 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $28M | $25M | $59M | $45M | $23M | $27M | $27M | $14M | $20M | $13M | $11M | $7M | $6M | $5M | $7M | $6M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $34M | $31M | $64M | $49M | $28M | $31M | $31M | $18M | $25M | $17M | $14M | $10M | $10M | $8M | $10M | $9M | |
| Operating Income | $-34M | $-31M | $-64M | $-49M | $-28M | $-31M | $-31M | $-18M | $-25M | $-17M | $-14M | $-10M | $-10M | $-8M | $-10M | $-9M | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $193.0K | |
| Income Tax | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-33M | $-30M | $-62M | $-48M | $-26M | $-29M | $-29M | $-15M | $-22M | $-15M | $-13M | $-9M | $-8M | $-7M | $-9M | $-8M | |
| EPS (Basic) | · | · | · | $-0.61 | $-0.41 | $-0.46 | · | $-0.24 | $-0.34 | $-0.27 | $-0.29 | $-0.21 | $-0.19 | $-0.15 | $-0.04 | $-0.37 | |
| EPS (Diluted) | · | · | · | $-0.61 | $-0.41 | $-0.46 | · | $-0.24 | $-0.34 | $-0.27 | $-0.29 | $-0.21 | $-0.19 | $-0.15 | $-0.04 | $-0.37 | |
| Shares (Basic) | · | · | · | 78,324,767 | 64,027,892 | 63,964,008 | · | 63,806,158 | 63,801,792 | 53,553,707 | -87,797,703 | 43,903,738 | 43,897,603 | 43,897,603 | -33,144,540 | 22,228,228 | |
| Shares (Diluted) | · | · | · | 78,324,767 | 64,027,892 | 63,964,008 | · | 63,806,158 | 63,801,792 | 53,553,707 | -87,797,703 | 43,903,738 | 43,897,603 | 43,897,603 | -33,144,540 | 22,228,228 | |
| EBITDA | $-34M | $-31M | · | $-49M | $-28M | $-31M | · | $-18M | $-25M | $-17M | · | $-10M | $-10M | $-8M | · | $-9M |
Bilans 20
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $178M | $85M | $90M | $21M | $21M | $33M | $35M | $32M | $110M | $27M | $39M | $94M | $112M | $27M | $86M | |
| Prepaid Expense | $4M | $5M | $5M | $8M | $7M | $8M | $12M | $10M | $5M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $161M | $205M | $142M | $183M | $146M | $165M | $195M | $213M | $231M | $231M | $90M | $98M | $106M | $113M | $121M | $127M | |
| PP&E (Net) | $639.0K | $558.0K | $622.0K | $709.0K | $797.0K | $855.0K | $881.0K | $779.0K | $844.0K | $604.0K | $684.0K | $601.0K | $677.0K | $753.0K | $831.0K | $909.0K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $992.0K | $914.0K | $836.0K | |
| Other Non-current Assets | $480.0K | $504.0K | $523.0K | $542.0K | $561.0K | $582.0K | $596.0K | $621.0K | $636.0K | $678.0K | $659.0K | $634.0K | $644.0K | $632.0K | $638.0K | $643.0K | |
| Total Assets | $165M | $209M | $146M | $187M | $150M | $170M | $200M | $219M | $237M | $248M | $96M | $104M | $112M | $119M | $126M | $133M | |
| Accounts Payable | $8M | $9M | $5M | $11M | $4M | $2M | $2M | $2M | $3M | $2M | $1M | $756.0K | $2M | $695.0K | $2M | $849.0K | |
| Accrued Liabilities | $25M | $38M | $58M | $33M | $21M | $19M | $21M | $14M | $17M | $10M | $7M | $5M | $4M | $7M | $8M | $8M | |
| Current Liabilities | $34M | $48M | $65M | $45M | $27M | $22M | $24M | $16M | $21M | $13M | $10M | $7M | $7M | $8M | $11M | $9M | |
| Capital Leases | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Liabilities | $38M | $50M | $68M | $48M | $30M | $26M | $28M | $21M | $26M | $17M | $14M | $11M | $12M | $13M | $16M | $14M | |
| Common Stock | $103.0K | $103.0K | $83.0K | $86.0K | $64.0K | $64.0K | $64.0K | $64.0K | $64.0K | $64.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | |
| Paid-in Capital | $625M | $622M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-497M | $-464M | $-435M | $-372M | $-325M | $-298M | $-269M | $-240M | $-225M | $-203M | $-189M | $-176M | $-166M | $-158M | $-152M | $-142M | |
| AOCI | $-12.0K | $6.0K | $54.0K | $66.0K | $-9.0K | $54.0K | $148.0K | $358.0K | $-150.0K | $-25.0K | $81.0K | $7.0K | $12.0K | · | $-31.0K | $-40.0K | |
| Stockholders' Equity | $127M | $158M | $78M | $139M | $120M | $144M | $172M | $198M | $211M | $231M | $82M | $93M | $100M | $106M | $111M | $119M | |
| Liabilities + Equity | $165M | $209M | $146M | $187M | $150M | $170M | $200M | $219M | $237M | $248M | $96M | $104M | $112M | $119M | $126M | $133M | |
| Shares Outstanding | 103,882,937 | 103,882,937 | 83,090,392 | 85,590,392 | 64,027,892 | 64,027,892 | 63,815,065 | 63,806,628 | 63,802,517 | 63,800,017 | 43,909,069 | 43,905,903 | 43,269,200 | 43,269,200 | 43,269,200 | 43,269,200 |
Przepływy pieniężne 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-44M | $-45M | · | · | $-19M | $-27M | $-22M | $-25M | $-14M | $-10M | $-9M | $-9M | $-7M | $-8M | $-7M | $-6M | |
| CapEx | · | · | $0 | $23.0K | $19.0K | $49.0K | $179.0K | $62.0K | · | · | · | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-41M | $29M | · | · | $19M | $14M | $19M | $27M | $-63M | $-68M | $-3M | $-46M | $-10M | $92M | $-52M | $-3M | |
| Stock Issued | · | · | $-201.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-435.0K | $108M | · | · | · | · | $36.0K | $30.0K | $-334.0K | $162M | $0 | · | · | · | $-316.0K | · | |
| Net Change in Cash | $-85M | $93M | $-5M | $70M | $-539.0K | $-12M | $-3M | $3M | $-78M | $83M | $-12M | $-56M | $-17M | $85M | $-59M | $66M | |
| Free Cash Flow | · | · | · | · | · | $-27M | · | · | · | · | · | · | · | · | · | · |
Rentowność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -20.8% | -15.6% | · | -23.5% | -13.5% | -14.0% | · | -9.6% | -12.4% | -8.0% | · | -7.6% | -9.6% | -6.9% | · | -7.5% | |
| ROE | -26.5% | -19.6% | · | -28.3% | -15.8% | -15.6% | · | -10.7% | -13.9% | -8.7% | · | -8.6% | -11.2% | -8.0% | · | -8.7% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 4.3 | · | 4.1 | 5.5 | 7.5 | · | 13.1 | 10.9 | 18.0 | · | 15.0 | 14.6 | 14.2 | · | 13.5 | |
| Quick Ratio | 2.7 | 3.7 | · | 2.0 | 0.8 | 1.0 | · | 2.2 | 1.5 | 8.6 | · | 5.9 | 13.0 | 13.9 | · | 9.1 |
Wycena (TTM) 9
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-136M | $-133M | · | $-119M | $-93M | $-81M | · | $-61M | $-54M | $-39M | · | $-32M | $-32M | $-32M | · | $-43M | |
| Market Cap | $317M | $467M | · | $276M | $185M | $138M | · | $418M | $463M | $484M | · | $173M | $135M | $196M | · | $138M | |
| P/E | -1.8 | -2.6 | · | -1.9 | -2.0 | -1.6 | · | -6.2 | -7.2 | -9.3 | · | -4.3 | -2.7 | -3.1 | · | -1.4 | |
| P/B | 2.5 | 3.0 | · | 2.0 | 1.5 | 1.0 | · | 2.1 | 2.2 | 2.1 | · | 1.9 | 1.4 | 1.8 | · | 1.2 | |
| P / Tangible Book | 2.5 | 3.0 | · | 2.0 | 1.5 | 1.0 | · | 2.1 | 2.2 | 2.1 | · | 1.9 | 1.4 | 1.8 | · | 1.2 | |
| P / Cash Flow | · | -10.5 | · | · | · | -5.2 | · | · | · | -46.5 | · | · | · | -26.0 | · | · | |
| P / FCF | · | · | · | · | · | -5.2 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -56.4% | -38.2% | · | -53.2% | -50.2% | -60.9% | · | -16.2% | -13.9% | -10.8% | · | -23.3% | -37.7% | -32.7% | · | -70.3% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Zysk netto | $-166M | $-81M | $-37M | $-35M | $-51M |
| Rozwodniony EPS | — | $-1.32 | $-0.84 | $-1.37 | $-2.95 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 2.2 | 8.0 | 9.5 | 11.3 | 8.2 |
| Wskaźnik Szybkości | 1.3 | 1.4 | 2.8 | 2.5 | 7.9 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-113M | $-71M | $-34M | $-28M | $-42M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 179 emitentów · $259.1M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 36 (-16 vs poprzedni kw.) | 29 (+15 vs poprzedni kw.) | 63 (+11 vs poprzedni kw.) | 43 (0 vs poprzedni kw.) | +5.8M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. | $108 601 271 | 35 606 974 | 41,91% | Akcje |
| Blue Owl Capital Holdings LP | $27 947 629 | 9 163 157 | 10,79% | Akcje |
| Defilade Capital Management, L.P. | $11 193 912 | 3 670 135 | 4,32% | Akcje |
| Driehaus Capital Management LLC | $9 648 440 | 3 163 423 | 3,72% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $9 073 448 | 2 974 901 | 3,50% | Akcje |
| RTW INVESTMENTS, LP | $7 826 297 | 2 565 999 | 3,02% | Akcje |
| DAFNA Capital Management LLC | $6 124 900 | 2 008 164 | 2,36% | Akcje |
| GOLDMAN SACHS GROUP INC | $5 164 830 | 1 693 387 | 1,99% | Akcje |
| Qube Research & Technologies Ltd | $5 005 178 | 1 641 042 | 1,93% | Akcje |
| CITADEL ADVISORS LLC | $4 443 316 | 1 456 825 | 1,71% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $4 377 700 | 1 434 996 | 1,69% | Akcje |
| STATE STREET CORP | $4 306 002 | 1 411 804 | 1,66% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4 279 675 | 1 403 172 | 1,65% | Akcje |
| Woodline Partners LP | $4 272 593 | 1 400 850 | 1,65% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $4 065 763 | 1 333 037 | 1,57% | Akcje |
| FMR LLC | $2 858 750 | 937 295 | 1,10% | Akcje |
| SPHERA FUNDS MANAGEMENT LTD. | $2 824 312 | 926 004 | 1,09% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $2 730 479 | 895 239 | 1,05% | Akcje |
| Alyeska Investment Group, L.P. | $1 882 494 | 617 211 | 0,73% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 580 815 | 518 300 | 0,61% | Opcja sprzedaży |
| VANGUARD FIDUCIARY TRUST CO | $1 366 912 | 448 168 | 0,53% | Akcje |
| Fi3 FINANCIAL ADVISORS, LLC | $1 263 896 | 2 915 | 0,49% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1 218 604 | 399 542 | 0,47% | Akcje |
| MARSHALL WACE, LLP | $1 092 845 | 358 310 | 0,42% | Akcje |
| SummitTX Capital, L.P. | $1 074 466 | 352 284 | 0,41% | Akcje |
| Gem Investment Advisors, LLC | $974 533 | 319 519 | 0,38% | Akcje |
| Burkehill Global Management, LP | $915 000 | 300 000 | 0,35% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $907 201 | 297 443 | 0,35% | Akcje |
| HAP Trading, LLC | $848 766 | 262 776 | 0,33% | Akcje |
| ADAR1 Capital Management, LLC | $831 872 | 272 745 | 0,32% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $821 975 | 269 500 | 0,32% | Opcja kupna |
| CITADEL ADVISORS LLC | $732 610 | 240 200 | 0,28% | Opcja sprzedaży |
| TWO SIGMA INVESTMENTS, LP | $720 206 | 236 133 | 0,28% | Akcje |
| Seven Fleet Capital Management LP | $704 309 | 230 921 | 0,27% | Akcje |
| HAP Trading, LLC | $687 173 | 237 776 | 0,27% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $631 255 | 206 969 | 0,24% | Akcje |
| IEQ CAPITAL, LLC | $620 258 | 203 363 | 0,24% | Akcje |
| Caption Management, LLC | $588 705 | 193 018 | 0,23% | Akcje |
| Soleus Capital Management, L.P. | $573 711 | 188 102 | 0,22% | Akcje |
| Cubist Systematic Strategies, LLC | $523 775 | 162 159 | 0,20% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $520 254 | 170 575 | 0,20% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $503 726 | 165 156 | 0,19% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $486 990 | 108 220 | 0,19% | Akcje |
| DIADEMA PARTNERS LP | $447 243 | 146 637 | 0,17% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $440 505 | 144 428 | 0,17% | Akcje |
| UBS Group AG | $440 194 | 144 326 | 0,17% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $421 498 | 138 196 | 0,16% | Akcje |
| Point72 Asset Management, L.P. | $411 158 | 134 806 | 0,16% | Akcje |
| Nuveen Asset Management, LLC | $366 137 | 94 609 | 0,14% | Akcje |
| Mariner, LLC | $349 099 | 114 445 | 0,13% | Akcje |
| Squarepoint Ops LLC | $346 096 | 113 474 | 0,13% | Akcje |
| Man Group plc | $344 799 | 113 049 | 0,13% | Akcje |
| TWO SIGMA ADVISERS, LP | $339 562 | 89 124 | 0,13% | Akcje |
| BlackRock, Inc. | $330 178 | 108 255 | 0,13% | Akcje |
| CWM, LLC | $288 567 | 64 126 | 0,11% | Akcje |
| ExodusPoint Capital Management, LP | $275 760 | 90 413 | 0,11% | Akcje |
| GOLDMAN SACHS GROUP INC | $274 500 | 90 000 | 0,11% | Opcja kupna |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $272 550 | 63 680 | 0,11% | Akcje |
| CARY STREET PARTNERS FINANCIAL LLC | $259 250 | 85 000 | 0,10% | Akcje |
| JANE STREET GROUP, LLC | $224 895 | 73 736 | 0,09% | Akcje |
| RHUMBLINE ADVISERS | $219 249 | 71 888 | 0,08% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $210 249 | 68 934 | 0,08% | Akcje |
| Quantbot Technologies LP | $209 752 | 68 771 | 0,08% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $182 353 | 59 788 | 0,07% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $182 085 | 59 700 | 0,07% | Akcje |
| SIMPLEX TRADING, LLC | $178 754 | 58 608 | 0,07% | Akcje |
| XTX Topco Ltd | $168 387 | 55 209 | 0,06% | Akcje |
| CIBC WORLD MARKET INC. | $161 650 | 53 000 | 0,06% | Akcje |
| PRUDENTIAL FINANCIAL INC | $160 805 | 52 723 | 0,06% | Akcje |
| WINTON GROUP Ltd | $159 820 | 52 400 | 0,06% | Akcje |
| JOURNEY STRATEGIC WEALTH LLC | $158 670 | 35 260 | 0,06% | Akcje |
| FEDERATED HERMES, INC. | $152 579 | 50 026 | 0,06% | Akcje |
| BANK OF AMERICA CORP /DE/ | $145 190 | 47 603 | 0,06% | Akcje |
| Pale Fire Capital SE | $131 150 | 43 000 | 0,05% | Akcje |
| JPMORGAN CHASE & CO | $130 336 | 40 730 | 0,05% | Akcje |
| Next Level Private LLC | $127 185 | 41 700 | 0,05% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $125 709 | 41 216 | 0,05% | Akcje |
| HAP Trading, LLC | $121 388 | 373 500 | 0,05% | Opcja kupna |
| MetLife Investment Management, LLC | $121 384 | 39 798 | 0,05% | Akcje |
| HighTower Advisors, LLC | $114 979 | 37 698 | 0,04% | Akcje |
| Persistent Asset Partners Ltd | $113 991 | 37 374 | 0,04% | Akcje |
| DEUTSCHE BANK AG\ | $111 569 | 36 580 | 0,04% | Akcje |
| Velan Capital Investment Management LP | $100 650 | 33 000 | 0,04% | Akcje |
| CITIGROUP INC | $96 972 | 31 794 | 0,04% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $93 489 | 30 652 | 0,04% | Akcje |
| Bank of New York Mellon Corp | $92 510 | 30 331 | 0,04% | Akcje |
| JANE STREET GROUP, LLC | $86 010 | 28 200 | 0,03% | Opcja sprzedaży |
| STRS OHIO | $80 825 | 26 500 | 0,03% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $80 724 | 26 467 | 0,03% | Akcje |
| VANGUARD GROUP INC | $80 189 | 21 047 | 0,03% | Akcje |
| Invesco Ltd. | $79 669 | 26 121 | 0,03% | Akcje |
| CAPTRUST FINANCIAL ADVISORS | $76 894 | 25 211 | 0,03% | Akcje |
| Russell Investments Group, Ltd. | $76 756 | 25 166 | 0,03% | Akcje |
| COMMONWEALTH EQUITY SERVICES, LLC | $70 350 | 23 067 | 0,03% | Akcje |
| Cerity Partners LLC | $70 081 | 22 977 | 0,03% | Akcje |
| Engineers Gate Manager LP | $68 799 | 22 557 | 0,03% | Akcje |
| Cherry Tree Wealth Management, LLC | $68 688 | 15 264 | 0,03% | Akcje |
| Vanguard Global Advisers, LLC | $64 193 | 21 047 | 0,02% | Akcje |
| Walleye Trading LLC | $61 000 | 20 000 | 0,02% | Akcje |
| CITADEL ADVISORS LLC | $60 695 | 19 900 | 0,02% | Opcja kupna |
Insiderzy spółki 28 insiderów · 12 dyrektorzy generalni · 18 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Carole Ben-Maimon | President and CEO | 26 stycznia 2026 A | 368 276 | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Chief Executive Officer | 22 stycznia 2019 A | — | 0 | 0 | $0 |
| Michael Celano | Chief Financial Officer | 26 stycznia 2026 A | 215 785 | 0 | 0 | $0 |
| Patricia L Allen | Chief Financial Officer | 22 stycznia 2019 A | 19 793 | 0 | 0 | $0 |
| Thomas E. Hughes | President and Chief Scientific Officer | 28 czerwca 2018 S | 125 247 | 0 | 0 | $0 |
| Patrick Loustau | President | 31 marca 2016 A | — | 0 | 0 | $0 |
| Gopi Shankar | Chief Development Officer | 26 stycznia 2026 A | 76 443 | 0 | 0 | $0 |
| Russell Clayton | Chief Medical Officer | 26 stycznia 2026 A | 71 443 | 0 | 0 | $0 |
| Singhal Priya | Head of Research & Development | 2 kwietnia 2019 A | — | 0 | 0 | $0 |
| Brian Mcveigh | Chief Business Officer | 22 stycznia 2019 A | — | 0 | 0 | $0 |
| Dennis D Kim | Chief Medical Officer | 22 stycznia 2019 A | 21 443 | 0 | 0 | $0 |
| Alicia Secor | Chief Commercial Officer | 31 marca 2016 A | 0 | 0 | 0 | $0 |
| Thomas Edward Hamilton | Dyrektor | 6 lipca 2026 P | 714 798 | 2 | 0 | $667 000 |
| Joseph Truitt | Dyrektor | 19 maja 2026 A | 2 750 | 0 | 0 | $0 |
| Frank E Thomas | Dyrektor | 19 maja 2026 A | 7 000 | 1 | 0 | $25 000 |
| Jeffrey W Sherman | Dyrektor | 19 maja 2026 A | 5 000 | 1 | 0 | $25 000 |
| Jonathan S Leff | Dyrektor | 19 maja 2026 A | — | 0 | 0 | $0 |
| Peter Barrett | Dyrektor | 10 maja 2022 A | 4 643 327 | 0 | 0 | $0 |
| Thomas O Daniel | Dyrektor | 12 maja 2021 A | 19 452 | 0 | 0 | $0 |
| Wendy Everett | Dyrektor | 26 czerwca 2019 A | — | 0 | 0 | $0 |
| Cameron Geoffrey Mcdonough | Dyrektor | 26 czerwca 2019 A | 0 | 0 | 0 | $0 |
| Robert J Perez | Dyrektor | 26 czerwca 2019 A | 5 322 | 0 | 0 | $0 |
| John L Lamattina | Dyrektor | 26 czerwca 2019 A | 31 376 | 0 | 0 | $0 |
| Bruce Booth | Dyrektor | 3 stycznia 2018 A | 4 638 028 | 0 | 0 | $0 |
| Frances K Heller | Dyrektor | 13 października 2017 P | 47 961 | 0 | 0 | $0 |
| Kevin P Starr | Dyrektor | 24 września 2015 J | 370 323 | 0 | 0 | $0 |
| Avi Y. Goldberg | Dyrektor | 18 września 2015 S | 53 734 | 0 | 0 | $0 |
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC | Posiadacz 10% | 26 czerwca 2020 J | 8 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 3 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Deerfield Private Design Fund III, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Partners, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P., James E. Flynn ×12 zgłoszenia | 2 marca 2026 | 34,41% | Aneks | Inwestycja pasywna | SEC |
| Chondrial Therapeutics Holdings, LLC ×2 zgłoszenia | 30 czerwca 2020 | — | Pierwotne zgłoszenie | — | SEC |
| Chondrial Therapeutics, Inc. | 27 grudnia 2019 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 29 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| FSCC · Federated Hermes ETF Trust | 0,06% | 47 062 NS | 31 maja 2026 | N-PORT |
| BIB · ProShares Trust | 0,02% | 4 014 NS | 31 maja 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 316 227 NS | 30 kwietnia 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 20 396 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,00% | 2 221 NS | 31 maja 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 24 913 NS | 31 maja 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 12 923 NS | 30 kwietnia 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1 737 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1 755 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6 906 NS | 30 kwietnia 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1 788 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 44 NS | 31 maja 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 11 156 NS | 30 kwietnia 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 12 332 NS | 30 kwietnia 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 1 156 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| IWV · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IBB · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13 lipca 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | — | — | 20 lipca 2026 | Dziennie |
| IBRN · iShares Trust | — | — | 13 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 lipca 2026 | Dziennie |